ClinicalThought
View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Director, The Peter Doherty Institute for Infection and Immunity
Professor of Infectious Diseases
University of Melbourne
Consultant Infectious Diseases Physician
Alfred Hospital and Royal Melbourne Hospital
Melbourne, Australia
This program has been made available online.
Expert commentary on updates in vaccine development for RSV, from Dr Angela Branche and Clinical Care Options (CCO)
Angela Branche, MD
Released: April 7, 2022
Expert commentary on addressing barriers to vaccine uptake in older individuals, from Dr Barbara Resnick and Clinical Care Options (CCO)
Barbara Resnick, PhD, CRNP
Released: January 12, 2022
Dr David E. Griffith describes the complex role of in vitro susceptibility testing in the management of NTM lung disease, from Clinical Care Options (CCO)
David E. Griffith, MD
Released: December 1, 2021
Dr Princy N. Kumar describes the safety monitoring required of treatment for nontuberculous mycobacterial lung disease, from Clinical Care Options (CCO)
Princy N. Kumar, MD, FIDSA, MACP
Released: November 30, 2021
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.